Varenicline Tartrate Kit
Product Images NDC 69315-404

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 69315-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Continuingmonthbox (Continuingmonthbox)

Varenicline Tablets Continuing Month Box packaging label for oral film-coated tablets. Contains 56 tablets of 1 mg strength for 4 continuing weeks. Label indicates prescription use (Rx only) and includes storage instructions. Manufactured by Medley Pharmaceuticals Ltd. and labeled for Leading Pharma, LLC.*

FDA Label Image

Continuingpack (Continuingpack)

Varenicline tablets continuing pack label showing dosage strength of 1 mg with 56 film-coated tablets total in a multi-week blister pack layout. Packaging includes detailed patient instructions for gradual dosing across four weeks. Manufactured by Medley Pharmaceuticals Ltd and labeled for Leading Pharma, LLC. Contains storage, dosage, and NDC 69315-403-58 information.*

FDA Label Image

Startingmonthbox (Startingmonthbox)

The packaging label for Varenicline Tablets Starting Month Box by Leading Pharma, LLC. It contains 0.5 mg and 1 mg oral film-coated tablets, with 11 tablets for the starting week and 42 tablets for the continuing weeks. The label includes dosage instructions, storage guidelines, manufacturer information, and a barcode.*

FDA Label Image

Startingpack (Startingpack)

Varenicline Tablets Starting Pack blister card showing 0.5 mg (green) and 1 mg (blue) film-coated tablets. The pack contains 11 tablets of 0.5 mg strength for starting week and 42 tablets of 1 mg strength for continuing weeks. Labeler is Leading Pharma, LLC; manufactured by Medley Pharmaceuticals Ltd.*

FDA Label Image

Varenicline-01 (Varenicline 01)

Chemical structure diagram showing the molecular layout of varenicline tartrate, an active ingredient in the product VARENICLINE TARTRATE tablets by Leading Pharma, LLC.*

FDA Label Image

Varenicline-02 (Varenicline 02)

A bar graph titled 'Continuous Abstinence, Weeks 9 through 12' showing the percentage of continuous abstinence across five studies. The x-axis lists studies 2 through 5 comparing different treatments, including Varenicline 0.5 mg, Varenicline 1.0 mg, flexible Varenicline, Bupropion SR 150 mg BID, and placebo. The y-axis displays percentages from 0% to 60%. Bars illustrate varying abstinence rates with error bars indicating variability.*

FDA Label Image

Varenicline-03 (Varenicline 033)

A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' showing percentages on the y-axis (0% to 35%) across four studies (Study 2 to Study 5). Each study compares different treatments including Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, Bupropion SR 150 mg BID, and Placebo. The bars indicate abstinence rates with error bars for variability.*

FDA Label Image

Varenicline-04 (Varenicline 04)

A line graph comparing the percentage of continuous abstinent participants over nontreatment follow-up weeks for Varenicline 1.0 mg taken twice daily versus placebo. The x-axis represents follow-up duration in weeks, and the y-axis shows the percentage of continuous abstinent individuals, with Varenicline consistently maintaining higher abstinence rates than placebo throughout the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.